Literature DB >> 33088702

Comparative evaluation of effectiveness of autologous platelet rich plasma and intralesional corticosteroids in the management of erosive oral Lichen planus- a clinical study.

Upasana Sethi Ahuja1, Nidhi Puri1, Chandramani B More2, Ritu Gupta3, Deepak Gupta4.   

Abstract

PURPOSE: Oral Lichen planus is a potentially malignant autoimmune disorder, characterized by burning and pain in the affected mucosa which reduces the quality and comfort of patient's life. Various treatment modalities have been documented for OLP but due its malignant potential the alternative therapeutic approaches with least or no side effects are being in demand. One of such, yet unexplored treatment is Platelet rich plasma (PRP). This study aims to evaluate the effectiveness of intralesional PRP as compared to the Intralesional corticosteroids in the management of erosive OLP.
MATERIALS AND METHODS: The study sample consisted of 20 clinically and histopathologically confirmed patients of Erosive OLP among which 10 patients were given intralesional corticosteroids and 10 patients were administered intralesional PRP. All the patients were given weekly injections for 2 months and were followed up till 4 months for assessing the parameters such as pain/burning, erythema and size of the lesions.
RESULTS: The patients in both the groups showed a statistically significant reduction in all the assessed parameters of erosive lichen planus from baseline till 4 months of treatment and follow up. However, on comparison of the pain reduction, size of lesion and erythema scores between the two groups, the difference was found to be statistically insignificant.
CONCLUSION: The intralesional PRP was found to be of comparative effectiveness with respect to intralesional triamcinolone acetonide in the management of erosive OLP and with an added advantage of having less recurrence and no adverse effects.
© 2020 Published by Elsevier B.V. on behalf of Craniofacial Research Foundation.

Entities:  

Keywords:  Corticosteroids; Erosive lichen planus; Platelet rich plasma; Potentially malignant disorder

Year:  2020        PMID: 33088702      PMCID: PMC7557883          DOI: 10.1016/j.jobcr.2020.09.008

Source DB:  PubMed          Journal:  J Oral Biol Craniofac Res        ISSN: 2212-4268


  16 in total

Review 1.  Platelet rich plasma: biology and new technology.

Authors:  William S Pietrzak; Barry L Eppley
Journal:  J Craniofac Surg       Date:  2005-11       Impact factor: 1.046

Review 2.  Oral lichen planus: focus on etiopathogenesis.

Authors:  Márcia Rodrigues Payeras; Karen Cherubini; Maria Antonia Figueiredo; Fernanda Gonçalves Salum
Journal:  Arch Oral Biol       Date:  2013-05-06       Impact factor: 2.633

3.  Efficacy of intralesional betamethasone for erosive oral lichen planus and evaluation of recurrence: a randomized, controlled trial.

Authors:  Chuanxia Liu; Bing Xie; Yi Yang; Duanxian Lin; Caixia Wang; Mei Lin; Lin Ge; Hongmei Zhou
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-11

Review 4.  Platelet-rich plasma: a biomimetic approach to enhancement of surgical wound healing.

Authors:  Joseph S Fernandez-Moure; Jeffrey L Van Eps; Fernando J Cabrera; Zonia Barbosa; Guillermo Medrano Del Rosal; Bradley K Weiner; Warren A Ellsworth; Ennio Tasciotti
Journal:  J Surg Res       Date:  2016-08-26       Impact factor: 2.192

5.  Short-term clinical evaluation of intralesional triamcinolone acetonide injection for ulcerative oral lichen planus.

Authors:  Juan Xia; Chunyang Li; Yun Hong; Linglan Yang; Yulei Huang; Bin Cheng
Journal:  J Oral Pathol Med       Date:  2006-07       Impact factor: 4.253

Review 6.  The pathogenesis of oral lichen planus.

Authors:  P B Sugerman; N W Savage; L J Walsh; Z Z Zhao; X J Zhou; A Khan; G J Seymour; M Bigby
Journal:  Crit Rev Oral Biol Med       Date:  2002

Review 7.  Platelet-rich plasma therapy - future or trend?

Authors:  Robinder S Dhillon; Edward M Schwarz; Michael D Maloney
Journal:  Arthritis Res Ther       Date:  2012-08-08       Impact factor: 5.156

8.  Prevalence of oral lichen planus among a sample of the Egyptian population.

Authors:  Basma Mostafa; Enji Ahmed
Journal:  J Clin Exp Dent       Date:  2015-02-01

9.  A clinical study on oral lichen planus with special emphasis on hyperpigmentation.

Authors:  Ravi Teja Chitturi; Pandian Sindhuja; R Arjun Parameswar; Ramdas Madhavan Nirmal; B Venkat Ramana Reddy; Janardhanam Dineshshankar; Thukanayakanpalayam Ragunathan Yoithapprabhunath
Journal:  J Pharm Bioallied Sci       Date:  2015-08

10.  Platelet-Rich Plasma (PRP) Rinses for the Treatment of Non-Responding Oral Lichen Planus: A Case Report.

Authors:  Elisabetta Merigo; Aldo Oppici; Anna Parlatore; Luigi Cella; Fabio Clini; Matteo Fontana; Carlo Fornaini
Journal:  Biomedicines       Date:  2018-02-06
View more
  4 in total

1.  Efficacy of intralesional injections of platelet-rich plasma in patients with oral lichen planus: A pilot randomized clinical trial.

Authors:  AbdelHameed Hijazi; Wesam Ahmed; Soheir Gaafar
Journal:  Clin Exp Dent Res       Date:  2022-02-26

2.  Efficacy of injectable platelet-rich fibrin in the erosive oral lichen planus: a split-mouth, randomized, controlled clinical trial.

Authors:  Ebru Saglam; Zeliha Betul Ozsagir; Tugba Unver; Suzan Bayer Alinca; Ali Toprak; Mustafa Tunali
Journal:  J Appl Oral Sci       Date:  2021-10-04       Impact factor: 2.698

3.  Oral lichen planus: comparative efficacy and treatment costs-a systematic review.

Authors:  Shaiba Sandhu; Brittany A Klein; Malak Al-Hadlaq; Prazwala Chirravur; Amal Bajonaid; Yuanming Xu; Rossella Intini; Mai Hussein; Piamkamon Vacharotayangul; Herve Sroussi; Nathaniel Treister; Stephen Sonis
Journal:  BMC Oral Health       Date:  2022-05-06       Impact factor: 3.747

4.  Appraisal of Experimental Methods to Manage Menopause and Infertility: Intraovarian Platelet-Rich Plasma vs. Condensed Platelet-Derived Cytokines.

Authors:  E Scott Sills; Samuel H Wood
Journal:  Medicina (Kaunas)       Date:  2021-12-21       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.